Patents by Inventor Zhuoying WANG

Zhuoying WANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12242441
    Abstract: The present application discloses a method, system, and computer system for managing lineage data for data entities. The method includes generating lineage data, wherein generating the lineage data, and storing and indexing, in a data structure, the lineage data in association with the selected data entity. The generating the lineage data includes selecting a selected data entity, obtaining a query tree that was used to generate the selected data entity, and determining lineage data for the selected data entity based at least in part on the query tree.
    Type: Grant
    Filed: January 31, 2023
    Date of Patent: March 4, 2025
    Assignee: Databricks, Inc.
    Inventors: Tao Feng, Menglei Sun, Zhuoying Wang
  • Publication number: 20200316053
    Abstract: The present disclosure relates to a new use of anlotinib, and relates in particular to anlotinib inhibiting osteosarcoma and chondrosarcoma growth and metastasis. It has been discovered for the first time that anlotinib can inhibit osteosarcoma and chondrosarcoma growth and metastasis. Anlotinib can significantly inhibit the growth of the osteosarcoma cell lines 143B, U2OS, MG63 and SJSA, induce cycle arrest in said cell lines, and can also inhibit osteosarcoma cell line migration and invasion. It has also been discovered for the first time that anlotinib can enhance the killing effect of the chemotherapeutic drug cisplatin on osteosarcoma cells.
    Type: Application
    Filed: June 17, 2020
    Publication date: October 8, 2020
    Inventors: Yingqi HUA, Gangyang WANG, Zhengdong CAI, Zhuoying WANG, Tao ZHANG, Hongsheng WANG, Mengxiong SUN, Xunqiang WANG, Xiaole ZHAN, Zhaoqiang YANG, Lifan TU, Pu LI